.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Deloitte
Medtronic
Farmers Insurance
Accenture
US Army
Citi
QuintilesIMS
Colorcon
Boehringer Ingelheim

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062602

« Back to Dashboard
NDA 062602 describes NYSTATIN AND TRIAMCINOLONE ACETONIDE, which is a drug marketed by Glenmark Pharms Ltd, Fougera Pharms Inc, Taro, Alpharma Us Pharms, Dr Reddys Labs Ltd, Pharmafair, Perrigo New York, Perrigo Uk Finco, Riconpharma Llc, and Teligent Pharma Inc, and is included in seventeen NDAs. It is available from thirteen suppliers. Additional details are available on the NYSTATIN AND TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in NYSTATIN AND TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.

Summary for NDA: 062602

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 062602

Ingredient-typePolyenes

Suppliers and Packaging for NDA: 062602

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NYSTATIN AND TRIAMCINOLONE ACETONIDE
nystatin; triamcinolone acetonide
OINTMENT;TOPICAL 062602 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0089 0168-0089-15 15 g in 1 TUBE (0168-0089-15)
NYSTATIN AND TRIAMCINOLONE ACETONIDE
nystatin; triamcinolone acetonide
OINTMENT;TOPICAL 062602 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0089 0168-0089-30 30 g in 1 TUBE (0168-0089-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength100,000 UNITS/GM;0.1%
Approval Date:Oct 9, 1985TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Cipla
Farmers Insurance
Cerilliant
Fish and Richardson
Medtronic
Dow
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot